Literature DB >> 8635234

Upregulation of cardiac uptake 1 carrier in ischemic and nonischemic rat heart.

M Ungerer1, A Chlistalla, G Richardt.   

Abstract

Neuronal uptake1 constitutes the main elimination process of cardiac norepinephrine under normoxic conditions. Uptake1 may be subject to changes during myocardial ischemia. We therefore studied the regulation of the uptake1 carrier in isolated perfused rat hearts, comparing ischemic and nonischemic conditions. Radioligand binding with [3H]mazindol was used to determine carrier densities and affinities, whereas cardiac clearance of[3H]norepinephrine served as a measure of the transport capacity of the uptake1 carrier. When exocytotic norepinephrine release was induced in nonischemic rat hearts by electrical field stimulations, we observed an increase in the cardiac density of uptake1 carriers (Bmax) to 210 +/- 5 fmol/mg protein (versus 134 +/- 3 fmol/mg in control hearts). Simultaneously, the cardiac clearance of [3H]norepinephrine increased to 41 +/- 4% versus 30 +/- 4% in control hearts. Both carrier density and norepinephrine clearance returned to baseline values within a period of 40 minutes after stimulation. Carrier affinities (Kd values) did not differ between the groups. Stop-flow ischemia induced a substantial overflow of norepinephrine by itself. Additionally, carrier density was increased to 144% after 40 minutes of stop-flow ischemia (P < .005 versus control hearts). When ischemia was followed by 20 minutes of reperfusion, the Bmax of the uptake1 carrier remained significantly elevated. With a further extension of the reperfusion period to 40 minutes, however, carrier density declined to baseline values. Kd values were not influenced by any of these interventions. Clearance of [3H]norepinephrine was suppressed (to 5 +/- 2%) in the first minutes of reperfusion, which may reflect the inverse transport direction of the norepinephrine carrier known to occur in ischemia. After 20 minutes of reperfusion, clearance increased to 39 +/- 5% (P < .005 versus control hearts) and then fell to 29 +/- 5% after 40 minutes of reperfusion (NS). These results demonstrate that after both electrical field stimulation and myocardial ischemia, the density of uptake1 carrier proteins temporarily increases, which may result in an increased transport capacity for norepinephrine.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8635234     DOI: 10.1161/01.res.78.6.1037

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  5 in total

1.  Reserpine-induced reduction in norepinephrine transporter function requires catecholamine storage vesicles.

Authors:  Prashant Mandela; Michelle Chandley; Yao-Yu Xu; Meng-Yang Zhu; Gregory A Ordway
Journal:  Neurochem Int       Date:  2010-02-20       Impact factor: 3.921

2.  Expressions of cardiac sympathetic norepinephrine transporter and beta1-adrenergic receptor decreased in aged rats.

Authors:  He Li; Xiao-qing Ma; Fan Ye; Jing Zhang; Xin Zhou; Zhi-hong Wang; Yu-ming Li; Guo-yuan Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2009-03       Impact factor: 3.066

3.  No-carrier-added versus carrier-added123I-metaiodobenzylguanidine for the assessment of cardiac sympathetic nerve activity.

Authors:  Hein J Verberne; Kora de Bruin; Jan B A Habraken; G Aernout Somsen; Jos L H Eersels; Frits Moet; Jan Booij; Berthe L F van Eck-Smit
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-01-20       Impact factor: 9.236

4.  Activity of the uptake-1 norepinephrine transporter as measured by I-123 MIBG in heart failure patients with a loss-of-function polymorphism of the presynaptic alpha2C-adrenergic receptor.

Authors:  Myron C Gerson; Lynne E Wagoner; Nancy McGuire; Stephen B Liggett
Journal:  J Nucl Cardiol       Date:  2003 Nov-Dec       Impact factor: 5.952

5.  Binding of [3H]mazindol to cardiac norepinephrine transporters: kinetic and equilibrium studies.

Authors:  David M Raffel; Wei Chen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-07-22       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.